Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

NCT02638701 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Aneurysm
Stroke
Vasculitis
Tumor Necrosis Factor-alpha

Interventions

DRUG: Infliximab

Sponsor

University of California, San Francisco